about
Development of alginate-reinforced chitosan nanoparticles utilizing W/O nanoemulsification/internal crosslinking technique for transdermal delivery of rabeprazole.Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: Preparation, characterization, in vitro, ex vivo and clinical evaluation.Maximizing the encapsulation efficiency and the bioavailability of controlled-release cetirizine microspheres using Draper-Lin small composite design.Maximizing the Therapeutic Efficacy of Imatinib Mesylate-Loaded Niosomes on Human Colon Adenocarcinoma Using Box-Behnken Design.Glycosylated Sertraline-Loaded Liposomes for Brain Targeting: QbD Study of Formulation Variabilities and Brain Transport.Polymeric nanoparticles: Promising platform for drug delivery.Depot injectable atorvastatin biodegradable in situ gel: development, optimization, in vitro, and in vivo evaluation.Development and optimization of carvedilol orodispersible tablets: enhancement of pharmacokinetic parameters in rabbits.Utilization of nanotechnology to enhance percutaneous absorption of acyclovir in the treatment of herpes simplex viral infections.Miconazole nitrate oral disintegrating tablets: in vivo performance and stability studyEnhanced permeation parameters of optimized nanostructured simvastatin transdermal films: ex vivo and in vivo evaluation.Optimized sildenafil citrate fast orodissolvable film: a promising formula for overcoming the barriers hindering erectile dysfunction treatment.Diacerein niosomal gel for topical delivery: development, in vitro and in vivo assessment.Self-Nanoemulsifying Lyophilized Tablets for Flash Oral Transmucosal Delivery of Vitamin K: Development and Clinical Evaluation.Matrix-type transdermal films to enhance simvastatin ex vivo skin permeability.Development of optimized self-nanoemulsifying lyophilized tablets (SNELTs) to improve finasteride clinical pharmacokinetic behavior.A PLGA-reinforced PEG in situ gel formulation for improved sustainability of hypoglycaemic activity of glimepiride in streptozotocin-induced diabetic rats.Design and optimization of self-nanoemulsifying delivery system to enhance quercetin hepatoprotective activity in paracetamol-induced hepatotoxicity.Optimization of self-nanoemulsifying systems for the enhancement of in vivo hypoglycemic efficacy of glimepiride transdermal patches.Enhancing the Therapeutic Efficacy of Tamoxifen Citrate Loaded Span-Based Nano-Vesicles on Human Breast Adenocarcinoma Cells.Pomegranate extract-loaded solid lipid nanoparticles: design, optimization, and in vitro cytotoxicity study.Transdermal film-loaded finasteride microplates to enhance drug skin permeation: Two-step optimization study.Stimuli-Responsive Nano-Architecture Drug-Delivery Systems to Solid Tumor Micromilieu: Past, Present, and Future PerspectivesOptimization of carvedilol solid lipid nanoparticles: An approach to control the release and enhance the oral bioavailability on rabbitsRisperidone oral disintegrating mini-tablets: A robust-product for pediatricsStatistical optimization of controlled release microspheres containing cetirizine hydrochloride as a model for water soluble drugsOptimized vinpocetine-loaded vitamin E D-α-tocopherol polyethylene glycol 1000 succinate-alpha lipoic acid micelles as a potential transdermal drug delivery system: in vitro and ex vivo studiesOptimization of the Factors Affecting the Absorption of Vardenafil from Oral Disintegrating Tablets: A Clinical Pharmacokinetic InvestigationZein-alpha lipoic acid-loaded nanoparticles to enhance the oral bioavailability of dapoxetine: optimization and clinical pharmacokinetic evaluationAn Optimized Surfactant-Based PEG-PLCL In Situ Gel Formulation For Enhanced Activity Of Rosuvastatin In Poloxamer-Induced Hyperlipidemic RatsChitosan-TPP nanoparticles stabilized by poloxamer for controlling the release and enhancing the bioavailability of doxazosin mesylate: in vitro, and in vivo evaluationSuperiority of TPGS-loaded micelles in the brain delivery of vinpocetine via administration of thermosensitive intranasal gelInvestigating the Potential of Transmucosal Delivery of Febuxostat from Oral Lyophilized Tablets Loaded with a Self-Nanoemulsifying Delivery System
P50
Q35201711-BB9E00F0-3889-4D48-BE0C-5B198A9D6ADAQ35896051-C107C77B-290E-4F21-B072-7DF6F527FB6AQ36631651-04F1F261-4C33-42FB-BEA2-E3DD2DD8B1FBQ38750915-97168F1F-338B-4177-A5B5-845A2B09B9C1Q38801605-60CB8CD0-7095-456D-A20F-66F85552D621Q39384145-C3C9A52A-2CB3-4AE9-BEBA-B99955980107Q40014643-E4C69AE9-7B7D-4481-A2C5-53B2104B9FA4Q41124333-A255EACA-95B5-4C71-87D4-4973043FABCAQ41140880-DAC17DBF-17B4-4FA1-9D70-D4B261AA4375Q41988280-B5C4E22E-166B-4B55-92E1-D072F4D9D9BFQ43786427-987D10E0-2F02-4D28-8E90-AF9699941906Q46183523-43C673F5-11C5-4BF2-AA14-415F770E33FBQ46217154-4AE83F3F-03E8-4B40-A115-FC5A327806B9Q46375551-69A2662F-BB71-4E74-988C-F2068ACE4F59Q46476748-B54C0701-D95B-47E2-A3CE-F6DF0A180AF3Q46835371-6FA31722-5677-49BF-90F6-623813530F70Q47100894-C0A46245-FB55-4E21-9B3D-DDC10E5D3E2AQ48375550-22EABF45-9E8C-4D6B-8CA0-DCAB74BC5E48Q51096935-262FE0FF-F460-498F-BC4B-B0D2ABE85EE4Q52730981-5A420EF3-02AE-4A88-B4E2-F472D469CEB9Q53699628-0E8C134E-688C-40ED-8A80-F680EFD12460Q53768573-AA9723B6-801D-43D8-8508-5BF3D08320E8Q57795140-F6EA3A2E-40D2-49C4-9485-2AB375B826FEQ58227147-AB16417C-88F3-4751-B845-C934C49ADE58Q58227185-493E6CD1-AA64-4E41-A8F0-468535ACD561Q58227190-0ED73648-6AF9-4FA6-B8C1-1A6F7F64E60DQ60301109-601BCDD5-D48F-428A-A858-CF605D1DF9A9Q61810479-CDF7C8C7-B232-4049-98BA-576E373B3EE0Q91111411-C95ADAA4-11E2-40EC-B818-4C8D9C954501Q91992477-8FB89AF2-FBCB-4E48-9B1A-06906D738892Q92452416-F94E9985-149F-40F5-851B-C2AF9DB6C966Q92626243-2DEAE86E-AADF-4AE1-A3D4-1313E9C4962AQ96344901-8775CBC3-FBA7-43E5-B738-46F6B5FCB231
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Khalid M El-Say
@ast
Khalid M El-Say
@en
Khalid M El-Say
@es
Khalid M El-Say
@nl
Khalid M El-Say
@sl
type
label
Khalid M El-Say
@ast
Khalid M El-Say
@en
Khalid M El-Say
@es
Khalid M El-Say
@nl
Khalid M El-Say
@sl
prefLabel
Khalid M El-Say
@ast
Khalid M El-Say
@en
Khalid M El-Say
@es
Khalid M El-Say
@nl
Khalid M El-Say
@sl
P106
P1153
36995725100
P31
P496
0000-0002-5539-3193